Ascend works with dialysis clinics to provide industry-leading service, comprehensive testing, innovative tools and technology.

Chronus develops in-vitro point-of-care devices leveraging microfluidics and semiconductor technologies.

RealTime provides software for clinical trial research sites, site networks, sponsors and CROs to manage complex clinical research processes

Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countriies.

Akura Medical is developing a next generation thrombectomy device to remove blood clots.

Renovo is one of the only national providers focused exclusively on managing health care and life sciences equipment and technology,

Signify Health has created a partner ecosystem that connects value-based solutions focused on improving care in and around the home.

With over 15,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record.

BIOiSIM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry.

he Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way.

Avenge Bio is developing transformative cell-based immunotherapeutic products for the treatment of intractable solid tumors.

Caira's proprietary technology seeks to revolutionize the usability, safety, and accessibility of advanced surgical navigation and robotics.

Offering a suite of scalable HR solutions available in the marketplace, Insperity is defined by an unrivaled breadth and depth of services.

Amberstone’s T-MATE therapeutic molecules enabled by its innovative single-cell discovery engine represents a real breakthrough.

Curi Bio’s technology platforms create value for pharma and biotech companies by accelerating discovery timelines and increasing success.

DiRx is an online pharmacy that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance.

Trait is developing cannabinoid technologies delivering water-soluble extracts to formulate higher quality CBD infused products.

Curi Bio’s technology platforms create significant value for pharma and biotech companies by accelerating discovery timelines.

Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics.

Unlike tank-based systems, GENOSYL DS generates NO at the bedside using a small disposable cassette.

The company's FlowSense™ noninvasive wireless sensor addresses a clinical unmet need for patients with hydrocephalus.

Oncorena's Phase I/II clinical trial of orellanine will enrol patients with advanced renal cancer already on dialysis due to renal failure.

The use of funds will include clinical program expansion and commercialization of the CAPTIS full-body embolic protection system.

Apella’s products include sensors installed in the operating room and harness artificial intelligence approaches to collect and analyze data

The financing provides capital to complete the clinical trial for the Ventura Interatrial Shunt for the treatment of advanced heart failure.

Zing Health was spun out of the American Medical Association's Health2047 innovation lab in 2019.

Nicoya’s solutions are currently being used by over 500 of the world’s leading researchers.

The company has raised more than $18 million to date from institutional investors, family offices, and more than 50 physician champions.

Soarta Biomedical's Biomimetic Implant is a minimally invasive treatment for chondral or osteochondral defects of the knee cartilage.

PCI brings the proven experience that comes with more than 50 successful product launches each year and over five decades in the business

Rising focuses on the development, regulatory, and commercial aspects of the product life cycle while outsourcing manufacturing.

In 2020, the Lithuanian biotech sector showed annual growth of 87% producing enormous profit for stakeholders.

"Our team has a groundbreaking approach to early detection of cancer."

Corganics' clinical cannabinoid therapy portfolio is available exclusively through healthcare professionals.

Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics.

"Our mission is to improve human health by providing scientists with the tools they need to measure proteins at high resolution...

Linus Biotechnology's pipeline consists of precision exposome medicine biomarkers and target discovery across disease domains.

We are currently developing an innovative therapeutic drug platform through strong partnerships with the University of Texas...

NanoMosaic is leveraging the power of nanoneedles, MosaicNeedle, for protein detection and quantification to develop alloys for biomarkers.

Curexa’s broad range of services include pre-launch support, customized formulations, API integration, and packaging/branding

Avivomed is developing and commercializing next generation neuromodulaton technology to treat patients suffering from chronic diseases.

MANA Therapeutics is harnessing the natural immune system to develop broadly accessible, ready-to-use cellular therapies to improve outcomes

yCoV-D® was recently granted emergency use approval (EUA) by India’s national regulatory agency for subjects 12 years and above.

Lunit develops AI-powered diagnostic tools for cancer screening, and biomarkers that can predict patients who respond to specific therapies.

THE study is designed to determine the extent to which LB-100 enters recurrent GBMs and related brain tumors.

Evoq is focused on technology available to doctors and scientists to enable them to discover and develop new treatments for blindness.

Migraine is the sixth most disabling illness in the world, which affects around a billion people worldwide.

The company's lead product utilizes a novel, non-invasive drug-device combination for outpatient treatment of rGBM.

We are excited to be commercializing Nasitrol nasal spray, a product that has shown such promise as a prophylaxis against COVID transmission

Bayshore uses its extensive knowledge and experience in global API and Finished Dosage Form manufacturing to differentiate itself.